Percutaneous treatment of a post-TAVI ventricular septal defect: a successful combined procedure for an unusual complication.

In this report, we present the successful percutaneous ventricular septal defect (VSD) closure, just 1 week post-transcatheter aortic valve implantation (TAVI). Periprocedurally, after implantation of the 31-mm CoreValve in an intentionally "high" position, we balloon postdilated, with an excellent result. A week post-TAVI, the patient started to deteriorate. Echocardiogram revealed a good working prosthesis; however, a perimembranous VSD was evident, causing significant shunt. We proceeded with interventional treatment of the defect, using an Amplatzer multifenestrated--"Cribriform"--septal occluder. Six months after the combined procedure, the patient showed marked improvement in symptoms and no shunt was observed.